PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

106, 2022

Gian Franco Zannoni et al., Biomarker characterization in endometrial cancer in Italy: first survey data analysis

1905, 2022

Ria Winkelmann et al., MSI status and p53 expression in benign and malignant salivary gland neoplasms

1305, 2022

Mario Caccese et al., Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study

605, 2022

Cristina Morelli et al., Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping

105, 2022

Mario Rizzato et al., Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study

2704, 2022

Bruno Perotti et al., Comparison of Survival Analysis After Surgery for Colorectal Cancer in Above 80 Years (Oldest-Old) and Below 80 Years Old Patients

2704, 2022

Silvia Strambi et al., Intestinal Ischemia: Unusual but Fearsome Complication of COVID-19 Infection

2504, 2022

Lucrezia Togni et al., Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis

704, 2022

Veronica Zelli et al., Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report

504, 2022

Antonio Matrone et al., Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses

504, 2022

Antonio Matrone et al., Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses

2603, 2022

Elisabetta Macerola et al., Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations

Previous 101112 Next